ClinicalTrials.Veeva

Menu

Validity and Reliability Study of the Pain Indicator Behavior Scale-Brain Damage (ESCID-DC)

C

Candelas Lopez Lopez

Status

Enrolling

Conditions

Behavior
Brain Injuries
Pain

Treatments

Other: Pain assessment using a behavioral scale

Study type

Observational

Funder types

Other

Identifiers

NCT04898491
ESCID-DC

Details and patient eligibility

About

A multicentre observational study to validate the adaptation of the Pain Indicator Behavior Scale (ESCID) for patients with acquired Brain Damage (ESCID-DC), as a measuring instrument.

Full description

Non-commercial study. The study complies with the ethical principles of the Declaration of Helsinki, the recommendations of Good Clinical Practice (GCP) and current legislation.

The study has been approved with a favorable opinion by the CEIm of the Hospital Universitario 12 de Octubre.

Written consent will be requested from the participants and / or their relatives / representatives to participate in the study.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age equal to or greater than 18 years.
  2. Inability to communicate verbally or motor.
  3. Have a artificial airway.
  4. Informed consent of the family member or representative of the patient.

Exclusion criteria

  1. Previous pathology of cognitive impairment.
  2. Previous brain injury.
  3. Previous psychiatric disorder.
  4. Previous dementia.
  5. Previous chronic substance abuse.
  6. Previous chronic diabetics.
  7. Previous spinal cord injury.
  8. Previous severe polyneuropathy (diagnosed or suspected).
  9. Confirmed diagnosis of brain death.
  10. Continuous infusion of muscle relaxants and / or barbiturate coma.
  11. Level of deep sedation (RASS -5).

Trial contacts and locations

1

Loading...

Central trial contact

Candelas López-López, PhD; Santiago Pérez-García, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems